These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1850101)

  • 1. Rapid uptake of tyrphostin into A431 human epidermoid cells is followed by delayed inhibition of epidermal growth factor (EGF)-stimulated EGF receptor tyrosine kinase activity.
    Faaland CA; Mermelstein FH; Hayashi J; Laskin JD
    Mol Cell Biol; 1991 May; 11(5):2697-703. PubMed ID: 1850101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tyrphostin on cell growth and tyrosine kinase activity of epidermal growth factor receptor in human gliomas.
    Miyaji K; Tani E; Shindo H; Nakano A; Tokunaga T
    J Neurosurg; 1994 Sep; 81(3):411-9. PubMed ID: 8057149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor signaling cascade as target for tyrphostin (RG 50864) in epithelial cells. Paradoxical effects on mitogen-activated protein kinase kinase and mitogen-activated protein kinase activities.
    Nowak F; Jacquemin-Sablon A; Pierre J
    Biochem Pharmacol; 1997 Feb; 53(3):287-98. PubMed ID: 9065732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation.
    Lyall RM; Zilberstein A; Gazit A; Gilon C; Levitzki A; Schlessinger J
    J Biol Chem; 1989 Aug; 264(24):14503-9. PubMed ID: 2788167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG; Carlin S; Workman P
    Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet B injury increases prostaglandin synthesis through a tyrosine kinase-dependent pathway. Evidence for UVB-induced epidermal growth factor receptor activation.
    Miller CC; Hale P; Pentland AP
    J Biol Chem; 1994 Feb; 269(5):3529-33. PubMed ID: 8106395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition.
    Fan Z; Lu Y; Wu X; DeBlasio A; Koff A; Mendelsohn J
    J Cell Biol; 1995 Oct; 131(1):235-42. PubMed ID: 7559780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.
    Gazit A; Yaish P; Gilon C; Levitzki A
    J Med Chem; 1989 Oct; 32(10):2344-52. PubMed ID: 2552117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein binding modulates inhibition of the epidermal growth factor receptor kinase and DNA synthesis by tyrphostins.
    Hoffman R; Dennis IF; Donaldson J
    Cancer Chemother Pharmacol; 1995; 36(4):316-24. PubMed ID: 7628051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the mitogen-activated protein kinase cascade by tyrphostin (RG 50864).
    Agbotounou WK; Mousset S; Piperno S; Pierre M; Jacquemin-Sablon A; Pierre J
    Biochem Pharmacol; 1994 Aug; 48(3):505-15. PubMed ID: 8068037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation.
    Peterson G; Barnes S
    Prostate; 1993; 22(4):335-45. PubMed ID: 8497428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrphostins inhibit the epidermal growth factor receptor-mediated breakdown of phosphoinositides.
    Posner I; Gazit A; Gilon C; Levitzki A
    FEBS Lett; 1989 Nov; 257(2):287-91. PubMed ID: 2555218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers.
    Dvir A; Milner Y; Chomsky O; Gilon C; Gazit A; Levitzki A
    J Cell Biol; 1991 May; 113(4):857-65. PubMed ID: 1709168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinase inhibitors and the contractile action of epidermal growth factor-urogastrone and other agonists in gastric smooth muscle.
    Yang SG; Saifeddine M; Hollenberg MD
    Can J Physiol Pharmacol; 1992 Jan; 70(1):85-93. PubMed ID: 1316219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor-specific protein tyrosine phosphorylation in preimplantation embryo development.
    Paria BC; Tsukamura H; Dey SK
    Biol Reprod; 1991 Nov; 45(5):711-8. PubMed ID: 1721842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tyrosine kinase inhibition on surfactant protein A gene expression during human lung development.
    Klein JM; DeWild LJ; McCarthy TA
    Am J Physiol; 1998 Apr; 274(4 Pt 1):L542-51. PubMed ID: 9575872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor. Phorbol ester or [Ca2+]i elevation can substitute for receptor activation.
    Soltoff SP
    J Biol Chem; 1998 Sep; 273(36):23110-7. PubMed ID: 9722539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tyrosine kinase activity decreases expression of surfactant protein A in a human lung adenocarcinoma cell line independent of epidermal growth factor receptor.
    Klein JM; McCarthy TA
    Biochim Biophys Acta; 1997 Mar; 1355(3):218-30. PubMed ID: 9060993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of protein-tyrosine kinases by tyrphostins.
    Levitzki A; Gazit A; Osherov N; Posner I; Gilon C
    Methods Enzymol; 1991; 201():347-61. PubMed ID: 1658552
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
    Reddy KB; Mangold GL; Tandon AK; Yoneda T; Mundy GR; Zilberstein A; Osborne CK
    Cancer Res; 1992 Jul; 52(13):3636-41. PubMed ID: 1617636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.